Kenvue focuses on consumer health portfolio, shares in S&P 500 peer comparison

Kenvue sits in the S&P 500 consumer health segment, with a broad portfolio of everyday brands like Tylenol and Neutrogena while investors track its position against peers such as Haleon and Procter & Gamble.

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-26, 14:57.

Kenvue (US49177J1025) operates as a consumer health company listed on the New York Stock Exchange, trading under the ticker KVUE in the S&P 500 index. The stock represents a large-scale portfolio of over-the-counter health and personal care brands that compete directly with Haleon and Procter & Gamble in the global consumer staples sector.

What recent data show

According to Hargreaves Lansdown company information, Kenvue has around 1.94 billion shares in issue and a market capitalization of approximately 36.10 billion US dollars, placing it firmly in the large-cap consumer non-cyclical segment of the S&P 500. The group employs roughly 21,780 people worldwide and is classified in the personal and household products industry. On the options-trading platform Public, Kenvue shares recently appeared with an indicative price of 18.96 US dollars, representing a move of 0.85 percent higher on that trading day, which offers retail investors a snapshot of short-term sentiment around the NYSE listing.

How analysts frame the sector

Third-party platforms such as Bitget describe Kenvue as a tokenized stock product linked to the NYSE-listed KVUE equity, reflecting investor interest in gaining exposure to consumer health names via both traditional and derivative trading structures. In the sector context, Kenvue competes with Haleon, Procter & Gamble and Colgate-Palmolive, where research houses typically highlight the defensive qualities of consumer health and hygiene brands and note that demand for everyday items like pain relief, oral care and skincare tends to be resilient across economic cycles per broader market commentary on consumer staples.

The brands behind the stock

Company information compiled by Hargreaves Lansdown states that Kenvue's differentiated portfolio includes widely known consumer health brands such as Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, Nicorette, Tylenol and Zyrtec. These brands are grouped into three reporting segments: Self Care, Skin Health and Beauty, and Essential Health, which covers over-the-counter medicines, allergy treatments and oral care products used daily in households worldwide.

Where the Kenvue shares trade

The Kenvue shares (US49177J1025) trade on the New York Stock Exchange in US dollars under the ticker KVUE, with recent indicative pricing around 18.96 US dollars per share on Public as of the latest referenced trading day. The listing belongs to the S&P 500 index and offers investors global exposure to the consumer non-cyclical personal and household products sector through a single large-cap stock.

Key data on the Kenvue shares

• Company: Kenvue Inc.
• ISIN: US49177J1025
• WKN: Not available
• Ticker: KVUE
• Trading venue: NYSE
• Price (as of 2026-06-26, 14:57): 18.96 USD
• Market cap: 36.10 billion USD (as of 2026-06-26)
• Sector / industry: Consumer non-cyclical, personal & household products
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not contain investment advice or recommendations. All data are based on publicly available sources believed to be reliable at the time of publication and may change without notice.